{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:50:38Z","timestamp":1773291038840,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00535-020-01751-2","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T17:03:01Z","timestamp":1606496581000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms"],"prefix":"10.1007","volume":"56","author":[{"given":"Yoshimasa","family":"Hoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Kawami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-6104","authenticated-orcid":false,"given":"Katsuhiko","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"1751_CR1","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","volume":"67","author":"CP Gyawali","year":"2018","unstructured":"Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351\u201362.","journal-title":"Gut"},{"key":"1751_CR2","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.3748\/wjg.v19.i39.6529","volume":"19","author":"M Cicala","year":"2013","unstructured":"Cicala M, Emerenziani S, Guarino MPL, et al. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol. 2013;19:6529\u201335.","journal-title":"World J Gastroenterol"},{"issue":"1250\u20131261","key":"1751_CR3","first-page":"e2","volume":"158","author":"SD Delshad","year":"2020","unstructured":"Delshad SD, Almario CV, Chey WD, et al. Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology. 2020;158(1250\u20131261):e2.","journal-title":"Gastroenterology"},{"key":"1751_CR4","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1053\/j.gastro.2016.02.012","volume":"150","author":"Q Aziz","year":"2016","unstructured":"Aziz Q, Fass R, Gyawali CP, et al. Esophageal disorders. Gastroenterology. 2016;150:1368\u201379.","journal-title":"Gastroenterology"},{"key":"1751_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/nmo.12620","volume":"27","author":"TVK Herregods","year":"2015","unstructured":"Herregods TVK, Troelstra M, Weijenborg PW, et al. Patients with refractory reflux symptoms often do not have GERD. Neurogastroenterol Motil. 2015;27:1267\u201373.","journal-title":"Neurogastroenterol Motil"},{"key":"1751_CR6","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/apt.14986","volume":"48","author":"M Ribolsi","year":"2018","unstructured":"Ribolsi M, Cicala M, Zentilin P, et al. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease. Aliment Pharmacol Ther. 2018;48:1074\u201381.","journal-title":"Aliment Pharmacol Ther"},{"key":"1751_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrgastro.2016.50","volume":"13","author":"E Scarpellini","year":"2016","unstructured":"Scarpellini E, Ang D, Pauwels A, et al. Management of refractory typical GERD symptoms. Nat Rev Gastroenterol Hepatol. 2016;13:281\u201394.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"211\u2013218","key":"1751_CR8","first-page":"e1","volume":"16","author":"R Yadlapati","year":"2018","unstructured":"Yadlapati R, Tye M, Roman S, et al. Postprandial high-resolution impedance manometry identifies mechanisms of nonresponse to proton pump inhibitors. Clin Gastroenterol Hepatol. 2018;16(211\u2013218):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1751_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.03.063","author":"A Sawada","year":"2020","unstructured":"Sawada A, Guzman M, Nikaki K, et al. Identification of different phenotypes of esophageal reflux hypersensitivity and implications for treatment. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.063.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1751_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01720-9","author":"A Sawada","year":"2020","unstructured":"Sawada A, Itami H, Nakagawa K, et al. Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom. J Gastroenterol. 2020. https:\/\/doi.org\/10.1007\/s00535-020-01720-9.","journal-title":"J Gastroenterol"},{"key":"1751_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ajg.2018.15","volume":"113","author":"E Glasinovic","year":"2018","unstructured":"Glasinovic E, Wynter E, Arguero J, et al. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Am J Gastroenterol. 2018;113:539\u201347.","journal-title":"Am J Gastroenterol"},{"key":"1751_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cgh.2014.04.018","volume":"13","author":"E Barba","year":"2015","unstructured":"Barba E, Burri E, Accarino A, et al. Biofeedback-guided control of abdominothoracic muscular activity reduces regurgitation episodes in patients with rumination. Clin Gastroenterol Hepatol. 2015;13:100-106.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1751_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/nmo.12737","volume":"28","author":"M Halland","year":"2016","unstructured":"Halland M, Parthasarathy G, Bharucha AE, et al. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil. 2016;28:384\u201391.","journal-title":"Neurogastroenterol Motil"},{"key":"1751_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/apt.13121","volume":"41","author":"H Jenkins","year":"2015","unstructured":"Jenkins H, Sakurai Y, Nishimura A, et al. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther. 2015;41:636\u201348.","journal-title":"Aliment Pharmacol Ther"},{"key":"1751_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2014a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"1751_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/apt.13331","volume":"42","author":"K Ashida","year":"2015","unstructured":"Ashida K, Sakurai Y, Nishimura A, et al. Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther. 2015;42:685\u201395.","journal-title":"Aliment Pharmacol Ther."},{"key":"1751_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13461","volume":"43","author":"K Ashida","year":"2016","unstructured":"Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: Vonoprazan, a novel potassium-competitive acid blocker, vslansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther. 2016;43:240\u201351.","journal-title":"Aliment Pharmacol Ther."},{"key":"1751_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000456072","volume":"95","author":"S Hoshino","year":"2017","unstructured":"Hoshino S, Kawami N, Takenouchi N, et al. Efficacy of vonoprazan for proton pump inhibitor-resistant reflux esophagitis. Digestion. 2017;95:156\u201361.","journal-title":"Digestion"},{"key":"1751_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.curtheres.2016.12.001","volume":"81\u201382","author":"Y Kinoshita","year":"2016","unstructured":"Kinoshita Y, Sakurai Y, Shiino M, et al. Evaluation of the efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a phase III, randomized, double-blind, placebo-controlled, multicenter study. Curr Ther Res Clin Exp. 2016;81\u201382:1\u20137.","journal-title":"Curr Ther Res Clin Exp"},{"key":"1751_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"1751_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/nmo.12477","volume":"27","author":"PJ Kahrilas","year":"2015","unstructured":"Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160\u201374.","journal-title":"Neurogastroenterol Motil."},{"key":"1751_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00535-017-1403-5","volume":"53","author":"Y Hanada","year":"2018","unstructured":"Hanada Y, Hoshino S, Hoshikawa Y, et al. Endoscopic diagnosis of hiatus hernia under deep inspiration is not consistent with esophageal manometric diagnosis. J Gastroenterol. 2018;53:712\u20137.","journal-title":"J Gastroenterol"},{"key":"1751_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s00535-019-01608-3","volume":"54","author":"S Kuribayashi","year":"2019","unstructured":"Kuribayashi S, Iwakiri K, Shinozaki T, et al. Clinical impact of different cut-off values in high-resolution manometry systems on diagnosing esophageal motility disorders. J Gastroenterol. 2019;54:1078\u201382.","journal-title":"J Gastroenterol"},{"key":"1751_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gut.2003.033290","volume":"53","author":"D Sifrim","year":"2004","unstructured":"Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024\u201331.","journal-title":"Gut"},{"key":"1751_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.14309\/ajg.0000000000000295","volume":"114","author":"K Nakagawa","year":"2019","unstructured":"Nakagawa K, Sawada A, Hoshikawa Y, et al. Persistent postprandial regurgitation vs rumination in patients with refractory gastroesophageal reflux disease symptoms: identification of a distinct rumination pattern using ambulatory impedance-pH monitoring. Am J Gastroenterol. 2019;114:1248\u201355.","journal-title":"Am J Gastroenterol"},{"key":"1751_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/nmo.12221","volume":"26","author":"N de Bortoli","year":"2014","unstructured":"de Bortoli N, Martinucci I, Savarino E, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil. 2014;26:28\u201335.","journal-title":"Neurogastroenterol Motil"},{"key":"1751_CR27","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, Van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u201320.","journal-title":"Am J Gastroenterol"},{"key":"1751_CR28","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/gut.2004.042945","volume":"53","author":"AJ Bredenoord","year":"2004","unstructured":"Bredenoord AJ, Weusten BLAM, Sifrim D, et al. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut. 2004;53:1561\u20135.","journal-title":"Gut"},{"key":"1751_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5056\/jnm15002","volume":"21","author":"N Koukias","year":"2015","unstructured":"Koukias N, Woodland P, Yazaki E, et al. Supragastric belching: Prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J Neurogastroenterol Motil. 2015;21:398\u2013403.","journal-title":"J Neurogastroenterol Motil"},{"key":"1751_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ajg.2013.428","volume":"109","author":"BF Kessing","year":"2014","unstructured":"Kessing BF, Bredenoord AJ, Smout AJPM. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol. 2014;109:52\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1751_CR31","first-page":"2258","volume":"56","author":"Y Kanda","year":"2015","unstructured":"Kanda Y. Statistical analysis using freely-available \u201cEZR (Easy R)\u201d software. Rinsho Ketsueki. 2015;56:2258\u201366.","journal-title":"Rinsho Ketsueki"},{"key":"1751_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1053\/gast.2001.27997","volume":"121","author":"J Fletcher","year":"2001","unstructured":"Fletcher J, Wirz A, Young J, et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 2001;121:775\u201383.","journal-title":"Gastroenterology"},{"key":"1751_CR33","first-page":"1","volume":"31","author":"L Frazzoni","year":"2018","unstructured":"Frazzoni L, Frazzoni M, De Bortoli N, et al. Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum. Ann Gastroenterol. 2018;31:1\u20137.","journal-title":"Ann Gastroenterol"},{"key":"1751_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00535-016-1226-9","volume":"52","author":"M Frazzoni","year":"2017","unstructured":"Frazzoni M, de Bortoli N, Frazzoni L, et al. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol. 2017;52:444\u201351.","journal-title":"J Gastroenterol"},{"key":"1751_CR35","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini V, Hasler WL, Malagelada JR, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380\u201392.","journal-title":"Gastroenterology"},{"key":"1751_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/MOG.0000000000000276","volume":"32","author":"JLS Ooi","year":"2016","unstructured":"Ooi JLS, Vardar R, Sifrim D. Supragastric belching. Curr Opin Gastroenterol. 2016;32:302\u20139.","journal-title":"Curr Opin Gastroenterol"},{"key":"1751_CR37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cgh.2018.05.049","volume":"16","author":"M Halland","year":"2018","unstructured":"Halland M, Pandolfino J, Barba E. Diagnosis and treatment of rumination syndrome. Clin Gastroenterol Hepatol. 2018;16:1549\u201355.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1751_CR38","doi-asserted-by":"publisher","first-page":"G314","DOI":"10.1152\/ajpgi.1998.275.2.G314","volume":"275","author":"M Thumshirn","year":"1998","unstructured":"Thumshirn M, Camilleri M, Hanson RB, et al. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol. 1998;275:G314\u201321.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1751_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13873","author":"Y Hoshikawa","year":"2020","unstructured":"Hoshikawa Y, Fitzke H, Sweis R, et al. Rumination syndrome: assessment of vagal tone during and after meals and during diaphragmatic breathing. Neurogastroenterol Motil. 2020. https:\/\/doi.org\/10.1111\/nmo.13873.","journal-title":"Neurogastroenterol Motil"},{"key":"1751_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ajg.2016.197","volume":"111","author":"E Barba","year":"2016","unstructured":"Barba E, Accarino A, Soldevilla A, et al. Randomized, placebo-controlled trial of biofeedback for the treatment of rumination. Am J Gastroenterol. 2016;111:1007\u201313.","journal-title":"Am J Gastroenterol"},{"key":"1751_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/jpet.117.244202","volume":"364","author":"N Takahashi","year":"2018","unstructured":"Takahashi N, Take Y. Tegoprazan, a novel potassium-competitive acid blocker to control gastric acid secretion and motility. J Pharmacol Exp Ther. 2018;364:275\u201386.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-020-01751-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T17:52:34Z","timestamp":1612461154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-020-01751-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1751"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01751-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"21 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Katsuhiko Iwakiri has received lecture fees from Takeda Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. The remaining authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}